Manufacturers Life Insurance Company, The Vertex Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 622,225 shares of VRTX stock, worth $252 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
622,225
Previous 633,575
1.79%
Holding current value
$252 Million
Previous $297 Million
2.55%
% of portfolio
0.27%
Previous 0.29%
Shares
33 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.39 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.64 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.79 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.65 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $104B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...